Evidence map›Paper›PMID 40188109›Full record

ArticleOrphanet journal of rare diseases2025

Analysis of the pathogenicity of novel GNE mutations and clinical, pathological, and genetic characteristics of GNE myopathy in Chinese population.

Yingming Xing, Lingqian Zhao, Renlong Zhao, Qiyun Liu, Juan Wang, Le Wang, Wei Zhang, Junhong Guo, Rongjuan Zhao, Xueli Chang

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yingming Xing *Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Lingqian Zhao *Department of Radiology, First Hospital, Shanxi Medical University, Taiyuan, China.
Renlong ZhaoDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Qiyun LiuDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Juan WangDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Le WangDepartment of Radiology, First Hospital, Shanxi Medical University, Taiyuan, China.
Wei ZhangDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Junhong GuoDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China.
Rongjuan ZhaoDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China. zhaorongjuan@sklmg.edu.cn.
Xueli ChangDepartment of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030012, China. changxueli841228@163.com.ORCID http://orcid.org/0000-0003-2599-1034

Funding

National Natural Science Foundation of China 82001222Shanxi Science and Technology Department 202203021212037
6 · The paper itself

Abstract

backgroundGNE myopathy is a rare autosomal recessive distal myopathy caused by mutations in UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), a bifunctional enzyme critical for sialic acid biosynthesis. This study aimed to describe a novel autosomal recessive GNE pedigree in a Chinese family and explore the possible mechanism of GNE variants in GNE myopathy, the most common distal myopathy in China. The clinical, genetic, and pathological characteristics of 216 Chinese patients with GNE myopathy were also summarized.

methodsThe proband and her family underwent a comprehensive medical history assessment and neurological examinations. Whole-exome sequencing was performed on the proband, and Sanger sequencing was performed on family members. 293T cell lines were used for immunofluorescence (IF), Western blot, and dual-luciferase reporter assays. We collected the clinical data of 216 GNE myopathy patients from previous reports up until August 1, 2024. Patients were classified into distinct groups according to mutation location to analyze genotype-phenotype correlation.

resultsWhole-exome sequencing of the proband and Sanger sequencing of all available family members identified a compound heterozygous mutation involving a novel promoter region mutation, c.-259T > C, and a reported mutation, c.88 C > T (p.Q30*). The GNE promoter fragment (-500 to -1; c.-259T > C) was cloned to construct the firefly luciferase reporter vector. The dual-luciferase reporter assay showed that the mutated promoter exhibited reduced transcriptional activity, resulting in decreased GNE expression. Western blot and IF analysis of overexpressing Q30* revealed that it reduced GNE expression without altering cellular localization and increased the ectopic cytoplasmic expression of TDP-43. The p.D207V mutation was the most common variant in China. Patients carrying p.D207V tended to experience later disease onset. In the epimerase/epimerase group, men experienced earlier disease onset than women (p < 0.05). In other groups, age at disease onset in females was earlier than that in males.

conclusionsThe c.-259T > C mutation decreases promoter activity, while the c.88 C > T (p.Q30*) mutation reduces GNE expression and affects TDP-43 distribution, thus affecting normal cellular function. The p.D207V mutation is the most common GNE variant in China and is associated with milder disease progression.

Indexed as

Distal MyopathiesMultienzyme ComplexesMutationAdolescentAdultChinaEast Asian PeopleFemaleHumansMaleMiddle AgedPedigreeMultienzyme ComplexesUDP-N-acetylglucosamine 2-epimerase - N-acetylmannosamine kinaseChinese GNE myopathyDistal myopathy with rimmed vacuolesGNE compound heterozygous mutationPromoter mutation

Identifiers

PMID40188109
PMCPMC11972457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.